Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Shapiro

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of the National Cancer Institute|May 19, 1993
Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodesC L Shapiro, R S Gelman, D F Hayes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B studyB L Samuels, D R Hollis, G L Rosner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patientsC L Shapiro, P H Hardenbergh, R Gelman, et al.
Urology|February 2, 2000
Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinomaW K Oh, J Manola, A A Renshaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 1992
Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancerC L Shapiro, R F Haft, N M Gantz, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2011
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809C L Shapiro, S Halabi, V Hars, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patientsC L Shapiro, L Ayash, I J Webb, et al.
European Journal of Cancer Care|November 26, 2015
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601E M L Smith, H Pang, C Ye, et al.
Breast Cancer Research and Treatment|December 28, 2011
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivoB Ramaswamy, W Fiskus, B Cohen, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of the National Cancer Institute|May 19, 1993
Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodesC L Shapiro, R S Gelman, D F Hayes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B studyB L Samuels, D R Hollis, G L Rosner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patientsC L Shapiro, P H Hardenbergh, R Gelman, et al.
Urology|February 2, 2000
Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinomaW K Oh, J Manola, A A Renshaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 1992
Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancerC L Shapiro, R F Haft, N M Gantz, et al.
European Journal of Cancer (Oxford, England : 1990)|February 18, 2011
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809C L Shapiro, S Halabi, V Hars, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patientsC L Shapiro, L Ayash, I J Webb, et al.
European Journal of Cancer Care|November 26, 2015
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601E M L Smith, H Pang, C Ye, et al.
Breast Cancer Research and Treatment|December 28, 2011
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivoB Ramaswamy, W Fiskus, B Cohen, et al.
Pageof 4